share_log

朗玛信息(300288.SZ):公司未开展干细胞业务

Guiyang Longmaster Information & Technology (300288.SZ): The company has not engaged in stem cell business.

Gelonghui Finance ·  Sep 20 04:44

Longmaster Information (300288.SZ) stated on the investor interaction platform on September 20th that the company does not engage in stem cell business, and Guiyang Liuyi, its subsidiary, currently has no plans to introduce strategic investors. The company's "39AI General Practitioner" has begun actively exploring the commercial landing form of the product, and the company will fulfill its disclosure obligations in a timely manner according to the progress of the product. Regarding the impairment of goodwill, the company will conduct impairment tests on goodwill at the end of each year, and the test results will be based on the relevant reports or opinions of intermediary institutions such as the company's annual audit accountants and assessors.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment